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To improve the detection of phosphorylated peptides/proteins, we developed a novel protocol
that involves the chemical derivatization of phosphate groups with a chemically engineered
biotinylated-tag (biotin-tag), possessing three functional domains; a biotin group for binding
to avidin, a base-labile 4-carboxy fluorenyl methoxycarbonyl (4-carboxy Fmoc) group, and a
nucleophilic sulfhydryl moiety on the side-chain of cysteine. Using this approach, the
derivatized, enzymatically digested peptides were selectively separated from unrelated
sequences and impurities on immobilized avidin. Unlike previously published phosphopep-
tide enrichment procedures, this approach upon treatment with mild base liberates a
covalently bound Gly-Cys analog of the peptide(s) of interest, exhibiting improved RP-HPLC
retention and MS ionization properties compared with the precursor phosphopeptide se-
quence. The results obtained for a model peptide Akt-1 and two protein digests, demonstrated
that the method is highly specific and allows selective enrichment of phosphorylated peptides
at low concentrations of fmol/L. (J Am Soc Mass Spectrom 2008, 19, 741–750) © 2008
American Society for Mass SpectrometryPhosphorylation is an important post-translationalmodification (PTM) representing a key regulatorymechanism for fundamental cellular events. Rou-
tine mapping of this transitory PTM is challenging for
the following reasons. First, the negatively-charged
phosphate group causes suppression of ionization in
positive mode mass spectrometry (MS). Second, low
stoichiometry of this modification in complex biological
mixtures makes its analysis challenging, and third, their
labile nature can affect the ability to assign precise sites
of modification. Furthermore, the hydrophilic character
of this groupmay cause some phosphopeptides to elute in
the void volume during reversed-phase high-performance
liquid chromatography (RP-HPLC) separation [1–4].
These factors underscore the need for continued
development of phosphopeptide enrichment methods
before mass analysis for identifying phosphorylation
sites in a complex biological mixture. Two-dimensional
HPLC systems using strong cation-exchange chroma-
tography (SCX), combined with RP-HPLC, as well as
immobilized metal affinity chromatography (IMAC)
techniques, are widely used for the enrichment of
phosphopeptides/proteins [5–14]. In the IMAC ap-
proach, the negatively-charged phosphate group on
phosphopeptides electroselectively binds to positively
charged Fe3 or Ga3 ions, which are immobilized on
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ever, in addition to binding phosphopeptides, these
metal ions will also bind nonspecific sequences rich in
negatively-charged residues. The nonselective binding
of these species can cause the displacement of phos-
phorylated peptides from the IMAC column resulting
in a decrease in the sensitivity of detection for the
peptides of interest. Dawoud et al. have combined
microfluidic separation techniques with MS for the high
throughput, contamination free analysis of phospho-
proteins [15]. Recently, some metal oxides such as
titanium and zirconium dioxide have been applied to
selectively concentrate phosphopeptides from complex
biological mixtures [16–19]. Although the titanium di-
oxide (TiO2) enrichment of phosphopeptides has been
shown to be very successful, it also suffers from non-
specific binding events. Several groups have attempted
to overcome these limitations by either washing the
TiO2 column with a solution containing NH4Glu,
which helped to increase recovery by up to 84% [20].
Wang et al. synthesized a porous anodic alumina
membrane for selective enrichment of phosphopeptides
[21]. Other groups have used magnetic immobilized
metal ions [22] and Fe3O4 and ZrO2 core-shell micro
spheres as affinity probes [23]. However, the labile
nature of the phosphate group on phosphopeptides
adds an additional element of difficulty with respect to
data interpretation, especially in trap-based mass ana-
lyzers [19, 24]. Thus, the MS3 scan mode was developed
for ion trap instruments, which has the ability to detect
Published online February 26, 2008
r Inc. Received November 9, 2007
Revised February 6, 2008
Accepted February 18, 2008
742 JALILI AND BALL J Am Soc Mass Spectrom 2008, 19, 741–750more diagnostic ions and, as a result, provides more
information about phosphorylation sites [24].
Chemical derivatization strategies based on -
elimination of phosphate moiety of phosphopeptides,
followed by a Michael’s addition reaction with S- and
N-nucleophiles are increasingly being described [25, 26].
Several studies report a combination of chemical deriva-
tization approaches and affinity chromatography for
the enrichment of phosphopeptides [27–29]. It was
demonstrated that affinity enrichment of phosphopep-
tides could be achieved by -elimination and Michael’s
addition of biotin or fluorous affinity tags, which were
attached covalently but were nonreversible [27, 29]. The
former method encountered a problem of incomplete
elution of modified biotinylated peptides from the avidin
column due to the strong binding affinity between avidin
and biotin, resulting in low recovery and loss of phos-
phopeptide [28].
In the present study, we have attempted to overcome
these problems, using a two-step -elimination and
Michael’s addition reaction to replace the phosphate
moiety with a reversible biotin-tag (Scheme 1). The
dihydroalanine intermediate, which is formed by the
loss of the phosphate group in alkaline conditions,
reacts with the sulfhydryl group on the side-chain of
Cys, resulting in the covalent attachment of the biotin-
tag. Substitution of the phosphate group with the
biotin-tag enables the enrichment of phosphopeptides
on immobilized avidin. The bound peptides are re-
leased into the supernatant upon treatment with a mildScheme 1. -Elimination and Michael’s addition reacbase such as triethylamine (TEA), resulting in the
addition of Gly-Cys dipeptide at the site of modification
whilst leaving biotin-spacer-4-carboxy Fmoc attached to
the avidin column. The eluent was then analyzed by
MALDI-MS and ESI-MS/MS. The experimental strat-
egy is given in Scheme 2 and represents a refinement of
a recently described method in which a reversible
His-tag was used to modify and enrich phosphopep-
tides from complex tryptic protein digests. In that
report, selective release from the Ni2-IMAC column
was achieved via a Factor Xa cleavage site incorporated
into the peptide sequence between the His-tag and the
Gly-Cys dipeptide [29]. The method described here
offers some significant advantages in that the tag is
smaller and therefore easier to couple, requires mild
base treatment instead of expensive Factor Xa to medi-
ate release, and is easier to produce in large quantities.
Furthermore, any potential steric problems that may
impede access by the enzyme to the Factor Xa cleavage
site are also eliminated. We will assess the effectiveness
of this novel approach by analyzing phosphopeptides
from a variety of sources.
Experimental
Amino acids and solvents were purchased fromNovabio-
chem (San Diego, CA) or Fisher Scientific (Fair lawn, NJ).
Ovalbumin, -casein (bovine) was purchased from Sigma-
Aldrich/New Jersey Center for Biomaterials (Piscat-
away, NJ). The materials used were barium hydroxidetion of phosphorylated peptide using biotin-tag.
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acid, trifluoroacetic acid (TFA), hydrogen peroxide,
triisopropylsilane (TIS), N,N-diisopropylethylamine
(DIEA), and triethylamine (TEA) (Sigma-Aldrich, Saint
Louis, MO), immobilized monomeric avidin (Pierce,
IL), Poros 20MC (PE Biosystems, Framingham, MA),
titanium oxide (ESPI, Ashland, OR), and sequencing-
grade modified trypsin, porcine (Promega, Madison,
WI); 2,5-dihydroxybenzoic acid (DHB) matrix was pur-
Scheme 2. Biotin enrichment strategy for the selective analysis of
phosphorylated peptide.chased from Agilent Technologies (Palo Alto, CA).Synthesis of Biotinylated Probe (Scheme 3)
One hundred mg (0.5 mmol) Boc-1,5-diaminopentane
was added to 120 mg (0.5 mmol) 4-carboxy Fmoc (1) in
CH2Cl2:DMF (1:1) in the presence of 105 mg (0.55 mmol)
1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydro-
chloride at 0 °C and stirred for 30 min. The Boc group
was removed using 1 mL of 5 M HCl in methanol. The
mixture was heated and refluxed for 4 h, the solution
cooled and then neutralized with 1 M NaOH in a
saturated solution of NaCl. The aqueous solution was
extracted with ethyl acetate and the two phases
separated. The organic phase, which contains the
product (3) was dried over anhydrous Na2SO4, the
solvent removed under reduced pressure to yield 126
mg (78%) of compound (3), which was analyzed by
ESI-MS (calc. 324.46; found 324.18). 110 mg (0.34 mmol)
compound (3) was added at room temperature to 248 mg
(0.68 mmol) of biotin p-nitrophenyl ester, stirred over-
night, and purified using flash chromatography. The
flash chromatography column was prepared by pour-
ing a slurry of silica gel (70–230 mesh, 60A), suspended
in dichlormethane:methanol (9:1) running buffer, into a
glass chromatography tube (100  15 mm) with a glass
sinter at one end. The compounds were eluted off the
column under positive pressure and collected in 2 mL
aliquots. Solvent was removed on a rotary evaporator,
resulting in a yield of 124 mg (67%) of the desired product
(4; calc. 550.79; found 550.26). 120 mg (0.22 mmol) of the
biotinylated intermediate (4) was activated with a 2-fold
excess of disuccinimidyl carbonate and the product puri-
fied on a C18 RP-HPLC semi-preparative column to yield
116 mg (76%) of the activated product (5; calc. 691.88;
found 691.22). The final biotin-tag (6) was prepared by
reacting a 5-fold excess of biotin-spacer 4-carboxy Fmoc
succinimidyl ester (5) with Gly-Cys peptidyl-resin for 1 h.
The resin was then cleaved for 90 min using 1 mL of
(5:95% vol/vol, triisopropylsilane:TFA) and purified on a
C18 RP-HPLC column, with a yield of 25.3 mg of [6] and
analyzed by MALDI-MS (Calc. 754.02; found 754.54).
Analytical RP-HPLC indicated 95% purity of the final
product (6). Analytical and semi-preparative RP-HPLC
was performed on a Waters 717 HPLC system (Waters,
Milford, MA), using Vydac C18 analytical (150 4.6 mm)
and semi-preparative (250  10 mm) columns. Separa-
tions were achieved by applying 100% B linear gradients
over 30 min at 1 mL/min or 120 min at 3 mL/min,
respectively. Solvent A was water/0.045% TFA and B
acetonitrile/0.036% TFA. Detection was at 220 nm.
Derivatization
For the model phosphopeptide; -elimination reac-
tions were performed with 10 L of phosphopeptide
(10 pmol), 5 L of 8 M guanidine HCl, 15 L of
acetonitrile, and 10 L of saturated barium hydroxide.
After 2 h reaction time at 45 °C (final concentration was
250 fmol/L), the resulting purified -eliminated pep-
tides were desalted on a C18 ZipTip (Millipore, Bed-
clea
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reaction. Due to the instability of the urethane bond to
Ba(OH)2, the second part of the reaction was performed
in 5% DIEA for 4 h. Thus, 5 L of resulting purified
-eliminated sample was added to 4 L of purified
biotin-tag (6) in ACN:DMF (1:1), 5 L of 8 M guanidine
and 1 L of DIEA. The resulting biotinylated peptide
was desalted using a C18 ZipTip.
For protein samples; before derivatization, the pro-
tein mixture was subjected to performic acid oxidation
by adding 50 L of 30% aqueous hydrogen peroxide:
formic acid (5:95 vol/vol) to 20 g of protein. The
reaction mixture was incubated overnight at 4 °C and
dried in a centrifugal vacuum system. The dried sample
was dissolved in 100 L of 100 mM ammonium bicar-
bonate. Trypsin digestion of oxidized proteins was
performed at 37 °C overnight using the substrate/
enzyme ratio of 100:1. The resulting mixture was di-
luted to 1 pmol/L using 0.1% formic acid of which 10
L was used for derivatization using the procedure
described above. Final concentration before enrichment
Scheme 3. Synthesis of the biotin probe. Reag
H2N(CH2)5NHBoc. (b)HCl, AcOEt, reflex. (c)
carbonate. (e) Gly-Cys resin, reflux, followed bywas 250 fmol/L.TiO2 Enrichment
TiO2 powder was resuspended in 80% ACN in 0.1%
TFA and then packed into an Eppendorf gel-loader tip,
which was blocked with a glass wool frit. To optimize
the binding of protein to the TiO2 microcolumn, the pH
of the digested proteins was adjusted to 6.5. The result-
ing mixture was introduced into the TiO2 microcolumn
and washed with 0.1% acetic acid, followed by 50%
ACN in 0.1% acetic acid. The bound phosphopeptides
were eluted with 0.5% ammonium hydroxide (pH 9.5).
Avidin Purification
The biotin-tagged peptides were enriched on a nanoscale
avidin column. First, the immobilized avidin resin was
equilibrated with the PBS binding buffer (0.1 M sodium
phosphate and 0.15 M NaCl, pH 7.4). A column was
prepared by loading the avidin resin into an Eppendorf
gel-loader tip and washed with PBS binding buffer. The
sample was diluted further in the binding buffer and
and conditions: (a) BtOH, EDCl, CH2Cl2, then
n p-nitrophenylester. (d) N,N=-disuccinimidyl
vage with 95%TFA, 5%TIS.ents
Biotiloaded onto the top of the column. The immobilized
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three times and eluted with a solution containing 5%
TEA and 2% ammonia in water to liberate the Gly-Cys
derivatized-peptides (note: biotin-spacer-4-carboxy Fmoc
remains attached to the avidin column).
Mass Spectrometry Analysis
Mass spectrometry analyses were performed using time
of flight MALDI-MS (Micromass LR MALDI-TOF; Mil-
ford, MA) and QTRAP 4000 triple quadrupole/linear
ion trap (MDS SCIEX, Ontario, Canada) instruments.
For MALDI-MS analysis, 0.5 L aliquot of a sample was
deposited onto a MALDI plate and then 0.5 L of the
working matrix 2,5-dihydroxybenzoic acid (DHB) solu-
tion slowly applied to the sample droplet. The sample-
matrix droplet was allowed to air dry at room temper-
ature. Typically, spectra were obtained using a pulsed
nitrogen UV laser (337 nm; 3 ns) in positive reflectron
mode; pulse voltage of 2800 mV; source voltage of
15,000 mV, using the MassLynx 4.0 Software (Waters,
Milford, MA). The following settings were used for the
QTRAP 4000 experiments: nano-ionspray voltage 2000
V, no heating of the source, curtain gas 20 psi, declus-
tering potential 110 V. Identification of phosphoryla-
tion sites and fragmentation was achieved by using
MS-product of Protein Prospector database.
Results and Discussion
Analytical Strategy
Published enrichment techniques such as Fe3 and
Ga3-IMAC, and TiO2, are very reliable ways for iso-
lating phosphopeptides. However they do suffer from
some drawbacks, such as copurification of nonspecific,
negatively-charged peptides. A convenient, quantita-
tive, site-specific modification of phosphate with a
group that exhibits enhanced MS ionization properties
is required. We synthesized a biotin tag that was
engineered to contain several important features for this
purpose. The tag consists of biotin linked to a 4-carboxy
Fmoc group through a spacer. The spacer is of sufficient
length to reduce steric hindrance between the peptide
chain and the biotin molecule, thus optimizing binding
to the immobilized avidin. The Fmoc moiety is com-
monly used in peptide synthesis as an N-terminal
protecting group for peptide synthesis. We exploited
the base-labile property of this group to provide the
desired reversibility, and thus allow the peptides of
interest to be released selectively and quantitatively
from the avidin column. The Cys residue at one end of
the tag provides the necessary sulfhydryl group for
reaction with the dihydroalanine intermediate follow-
ing -elimination. Mild base treatment cleaves the ure-
thane bond, leaving the biotin-spacer-4-carboxy Fmoc
group attached to the avidin column and releases
modified peptide sequence(s) with Gly-Cys covalently
attached at the site of phosphorylation. This modifi-cation is more amenable to MS analysis by eliminat-
ing the negatively-charged phosphate group, which
has a tendency to suppress ionization. The standard
-elimination/Michael’s addition reaction conditions,
which are performed at high pH, are not suitable for
our probe and therefore it was necessary to modify the
two-step procedure. Several bases were tested for use in
the Michael’s addition step and DIEA proved to have
the desired properties in that it did not cleave the Fmoc
group and the Michael’s addition reaction proceeded
well in the presence of the base.
The validity of these assumptions was confirmed
with well-defined model phosphopeptides/proteins,
using Akt-1, ovalbumin, and -casein. The experiments
were performed at least three times to optimize the
methodology and ensure reproducibility.
Model Peptide (Akt-1)
Amodel phosphopeptide Akt-1 was chemically synthe-
sized on an automated peptide synthesizer using Fmoc
chemistry with a phosphate group on Ser8 (Figure 1a,
calc., 1732.75; found 1732.78). Akt-1 was used to opti-
mize the protocol for the derivatization of phosphate
groups with the reversible biotin-tag (6). The MALDI-MS
spectrum of -eliminated peptide shows the peak ofm/z
1634.78 (Figure 1b) for the dihydroalanine intermediate,
corresponding to the loss of phosphate. The peak at m/z
2387.72 (Figure 1c) represents the phosphopeptide de-
rivatized with biotin-tag. The biotinylated peptide was
enriched on the nanoscale avidin column and the im-
mobilized peptide eluted with mild base (5% TEA and
2% ammonia in water). The eluent was then acidified
with 5% formic acid and desalted on a C18 ZipTip. The
MALDI-MS spectrum of modified peptide after treat-
ment with base, which leaves a Gly-Cys dipeptide at
the site of phosphorylation, is shown in Figure 1d. The
peak of m/z 1810.97 (calc. 1810.82) is clear in the
spectrum after enrichment, however, MS/MS sequenc-
ing is required to determine the site of phosphorylation
unambiguously. Figure 2 shows the MS/MS spectrum
of doubly charged ions of Gly-Cys modified peptide at
m/z 906.45. The nearly complete series of b and y ions
are clear in the resulting MS/MS spectrum that was
used to sequence the modified peptide. The data identi-
fied the following sequence RPHFPQFS(GC)YSASGTA,
thus confirming the site of phosphorylation at Ser8.
The addition of Gly-Cys results in the introduction of
an extra protonatable amine group, which enhances the
ionization efficiency of the peptide in positive-mode
MS, compared with precursor phosphorylated peptide.
Furthermore, the labile nature of phosphate group
complicates data interpretation requiring the need to
run MS3 experiments for complete sequence informa-
tion. Our approach offers some distinct advantages
because there is no loss of the covalently attached
Gly-Cys dipeptide in the mass spectrometer.
tion a
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To evaluate this methodology further we applied the
biotin-tag to the chemical derivatization of ovalbumin,
Figure 1. The MALDI-MS spectra of (a) mode
Michael’s addition, and (d) avidin purification an
at the phosphorylation site after avidin purifica
Figure 2. (Insert) MS/MS spectrum ofm/z 906.45
GTA. The enhanced resolution MS spectrum o
906.45 after avidin purification and base treatment.which possesses two sites of phosphorylation. Before
chemical derivatization, the protein was subjected to
performic acid treatment, which oxidizes cysteine, me-
sphorylated peptide, after (b) -elimination, (c)
se treatment. The modified peptide has Gly-Cys
nd base treatment.
corresponding sequence is RPHFPQFS(GC)YSAS-
bly charged Gly-Cys modified peptide at m/zl pho
d ba. The
f dou
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blocks any undesirable side reactions that may occur
between the Cys residue on the biotin-tag and Cys
residues present in the ovalbumin sequence. The
MALDI-MS spectrum of tryptic digest of ovalbumin is
shown in Figure 3a. Two arrows in this figure indicate
the peaks corresponding to phosphorylated peptides.
The peak intensity of the phosphopeptides is low com-
pared with the other tryptic peptides present in the
sample. For comparison of our novel method and
IMAC, the phosphorylated peptides in the tryptic mixture
were also enriched using TiO2. The peaks of phosphory-
lated peptides at m/z 2088.82 and 2893.21, corresponding
to EVVGSAEAGVDAASVSEEFR and FDKLPGFGDS-
IEAQCGTSVNVHSSLR, respectively, gain significant in-
tensity upon TiO2 enrichment (Figure 3b). However, the
peaks of nonspecific peptides are also present, resulting in
a more complex spectrum. Figure 3c shows phosphopep-
tide enrichment after biotin-tag derivatization, avidin cap-
ture, and base treatment. The peaks corresponding to the
phosphopeptides shift to m/z 2166.94 and 2971.71, respec-
tively, due to the addition of Gly-Cys dipeptide at each of
the two sites of phosphorylation. The MALDI-MS spec-
trum following biotin-avidin affinity enrichment was sig-
nificantly less complex than that obtained using TiO2
because nonspecific binders such as 1337.76 and 1774.94,
which are present in Figure 3b, are absent in Figure 3c.
Figure 3. The MALDI-MS spectra of (a) ovalbu
(c) avidin capture and base treatment. Two phos
at the sites of phosphorylation.To demonstrate that the ionization characteristics of the
Gly-Cys derivatized peptide were improved, an initial
MS/MS experiment was performed on the unmodified
phosphorylated precursor peptide after TiO2 enrichment
(Figure 4a). In the MS/MS spectrum of the corresponding
phosphopeptide, themost abundant and intense peakwas
that of the doubly charged ion highlighting the difficulty
of ionizing and fragmenting these phosphorylated spe-
cies. When the Gly-Cys modified peptide was frag-
mented, the triply charged ion was easily identified at the
same collision energy settings (Figure 4b). Although the b
and y ions dominate the spectrum, the series of y ions are
more complete, and better coverage was observed over
the high m/z region. The sequence obtained corresponds
to EVVGS(GC)AEAGVDAASVSEEFR with an increase in
mass of 158.05 Da on the b5 to b7 ions, which was
attributed to the addition of Gly-Cys dipeptide at the site
of phosphorylation.
Tryptic Digest; -Casein
-Casein, a milk-derived protein that possesses multi-
ple phosphorylation sites was also used to confirm our
enrichment methodology. The commercially available
-casein has two variants with low sequence homology.
Carr et al. [30] detected nine phosphorylation sites
using precursor ion scanning. However, they were not
before derivatization, after (b) TiO2 enrichment,
eptides were enriched which now have Gly-Cysmin
phop
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phosphopeptides with multiple phosphorylation sites, be-
cause of the ionization suppression effects described pre-
viously. The data obtained correlated with that found by
MALDI-MS using the His-tag/Factor Xa enrichment strat-
egy [29]. TheMS (inset) andMS/MS (Figure 5a) spectra of
one of the GC-derivatized peptides from -casein was
identified using a QTRAP 4000 MS instrument. Although
Figure 4. (a) MS/MS spectrum of m/z 1044.95
sequence is EVVGS(PO4)AEAGVDAASVSEEF
charged ion at m/z 1044.95 (inset). (b) MS/MS sp
base treatment to release the Gly-Cys modifie
(GC)AEAGVDAASVSEEFR. Enhanced resolutio
peptide at m/z 723.8 (inset).the y and b ions dominate the spectrum, the series of y ionsare more complete, and better coverage was observed
over the high m/z region. The fragment obtained corre-
sponds to YKVPQLEIVPNSAEER and the mass of 160.04
Da was added to all fragments from y5 to y15, which is
attributed to the addition of Gly-Cys dipeptide at the site
of phosphorylation (Ser12).
To demonstrate that the ionization characteristics of
the Gly-Cys derivatized peptide improved, another
ing enrichment with TiO2. The corresponding
nhanced resolution MS spectrum of doubly
m of m/z 723.8 following avidin enrichment and
ptide. The corresponding sequence is EVVGS
spectrum of triply charged Gly-Cys modifiedfollow
R. E
ectru
d pe
n MSMS/MS experiment was performed on the unmodified
ds to
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lision energy settings (Figure 5b). In the MS/MS spec-
trum of the corresponding phosphopeptide, the most
abundant and intense peak was that of the triply
charged ion highlighting the difficulty of ionizing and
fragmenting these phosphorylated species. In compar-
ison, the series of b and y ions are far more intense in the
case of the peptide modified with Gly-Cys. In agree-
Figure 5. (a) ESI-MS/MS and ESI-MS (inset) s
tide after modification, avidin enrichment, and b
ESI-MS/MS and ESI-MS spectra (inset) of the pre
m/z 976.8 for the [M  3H]3 ion and corresponment with the results, substitution of a negatively-charged phosphate with a protonatable group im-
proved ionization efficiency of the species of interest.
Conclusions
The combination of chemical derivatization with biotin-
tag and affinity enrichment using an avidin column is a
highly efficient approach towards identification of low
a of Gly-Cys derivatized -casein phosphopep-
reatment m/z 1016.6 for the [M  2H]2 ion. (b)
r phosphopeptide before His-tag derivatization
the YKVPQLEIVPNS(GC)AEER sequence.pectr
ase t
cursoconcentrations of phosphopeptides in complex mix-
750 JALILI AND BALL J Am Soc Mass Spectrom 2008, 19, 741–750tures. Replacement of the phosphate group with a
protonatable Gly-Cys dipeptide following avidin cap-
ture and base treatment enhances MS ionization effi-
ciency compared with the phosphorylated precursors,
augments CID backbone fragmentation and, as result,
facilitates phosphorylation site identification. Further-
more, this procedure adds elements of specificity and
selectivity, which aids the elimination of nonspecific
sequences that might otherwise compromise the enrich-
ment and subsequent analysis of low concentrations of
phosphopeptide. The Gly-Cys modification is also less
hydrophilic than the corresponding phosphorylated
peptide, thus improving its retention on RP chromato-
graphic media and allowing detection of phosphopep-
tides that might otherwise have been lost in the solvent
front.
Problems associated with the lability of phosphate
groups are overcome as a result of the covalent modi-
fication with Gly-Cys dipeptide, which remains at-
tached during mass analysis. The method we describe
offers some distinct advantages over the previously
reported His-tag derivatization approach in that the
biotin-tag is smaller and therefore easier to couple, is
less complicated to produce, and avoids the need for
expensive Factor Xa to release the enriched Gly-Cys
modified peptides from the affinity column. The result
of this research confirms that this innovative method
provides a reliable methodology for phosphopeptide
mapping of complex protein mixtures.
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